Hemostemix Inc. News

Hemostemix Announces Closing of UNIT Private Placement

June 22, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company“) is pleased to announce it closed […]


Hemostemix Announces the Incorporation of PreCerv Inc. And a Global Field of Use License to NCP-01

June 14, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company“) is pleased to announce it has […]


Hemostemix Announces Financing

May 19, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company“) is pleased to announce a non-brokered […]


Hemostemix Announces Pete Pavlin, P.Eng., Vice-President Operations

May 19, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is pleased to announce the […]


Hemostemix Announces Rick Groome as Special Advisor to The CEO

May 16, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is pleased to announce Mr. […]


Hemostemix Announces Its Intellectual Property is Back Home

May 10, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is pleased to announce […]